ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.64745
0.09%
Brent Oil
76.225
-0.37%
Bitcoin
99,192.02
0.90%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Alemania
  5. TG

  6. Mersana Therapeutics Inc (0M4) Cotización

Mersana Therapeutics Inc

Mersana Therapeutics Inc (0M4)

TG
1.3345
-0.025
(-1.84%)
Cerrado 05 Enero 3:00PM
Realtime Data

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
1.3345
Postura de Compra
1.3475
Postura de Venta
1.398
Volume Operado de la Acción
7,645
1.394 Rango del Día 1.4045
1.137 Rango de 52 semanas 5.628
Capitalización de Mercado [m]
160.917M
Precio Anterior
1.3595
Precio de Apertura
1.394
Hora
400
@
1.4045
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
2,819
Acciones en circulación
120,582,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.97
Beneficio por acción (BPA)
-1.42
turnover
36.86M
Beneficio neto
-171.67M

Acerca de Mersana Therapeutics Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.mersana.com
Sede
Wilmington, Delaware, USA
Fundado
-
Mersana Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker 0M4. The last closing price for Mersana Therapeutics was 1.36 €. Over the last year, Mersana Therapeutics shares have traded in a share price range of 1.137 € to 5.628 €.

Mersana Therapeutics currently has 120,582,000 shares in issue. The market capitalisation of Mersana Therapeutics is 163.93 € million. Mersana Therapeutics has a price to earnings ratio (PE ratio) of -0.97.

0M4 Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0575-4.130747126441.3921.43851.3549971.36519174DE
4-1.0555-44.16317991632.392.391.35438631.77821079DE
12-0.569-29.89230365121.90352.6031.35428191.88404507DE
26-0.4025-23.17213586641.7372.6031.13726071.69541253DE
52-0.658-33.02383939771.99255.6281.13716262.29634621DE
1560.233000121.15298421721.10149995.6281.058517752.06896402DE
2600.233000121.15298421721.10149995.6281.058517752.06896402DE

0M4 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Mersana Therapeutics?
El precio actual de las acciones de Mersana Therapeutics es 1.3345 €
¿Cuántas acciones de Mersana Therapeutics están en circulación?
Mersana Therapeutics tiene 120,582,000 acciones en circulación
¿Cuál es la capitalización de mercado de Mersana Therapeutics?
La capitalización de mercado de Mersana Therapeutics es EUR 163.93M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Mersana Therapeutics?
Mersana Therapeutics ha negociado en un rango de 1.137 € a 5.628 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Mersana Therapeutics?
El ratio precio/beneficio de Mersana Therapeutics es -0.97
¿Cuál es el ratio de efectivo a ventas de Mersana Therapeutics?
El ratio de efectivo a ventas de Mersana Therapeutics es 4.52
¿Cuál es la moneda de reporte de Mersana Therapeutics?
Mersana Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Mersana Therapeutics?
El último ingresos anual de Mersana Therapeutics es USD 36.86M
¿Cuál es el último beneficio anual de Mersana Therapeutics?
El último beneficio anual de Mersana Therapeutics es USD -171.67M
¿Cuál es la dirección registrada de Mersana Therapeutics?
La dirección registrada de Mersana Therapeutics es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Mersana Therapeutics?
La dirección del sitio web de Mersana Therapeutics es www.mersana.com
¿En qué sector industrial opera Mersana Therapeutics?
Mersana Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
0S6Cerence Inc
18.972 €
(145.34%)
89.94k
CY9DMicrobot Medical Inc
2.11 €
(89.07%)
24.21k
RV0Torrent Gold Inc
0.138 €
(73.58%)
1.23k
7CCCheckCap Ltd
1.76 €
(55.75%)
6.55k
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M
FASFastenal Co
9.7358 €
(-85.95%)
2.13k
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-45.45%)
300.18k
B4T0CuFe Ltd
0.0045 €
(-25.00%)
1
H5EHelma Eigenheimbau Ag
0.0766 €
(-23.40%)
751
2WOWide Open Agriculture Ltd
0.005 €
(-23.08%)
50k
PF8European Lithium Limited
0.0264 €
(8.20%)
5.76M
3CPXiaomi Corporation
4.597 €
(7.34%)
3.95M
D7GNel ASA
0.247 €
(2.66%)
2.33M
J9AVERSES AI Inc
1.352 €
(0.00%)
1.67M
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M

Discusión

Ver feed completo
Koan Koan 4 minutos hace
Everyone knows what this is about.

The three companies:

1. BioAmber Inc. - parent company (where the shares are)
2. BioAmber Sarnia - subsidiary
3. BioAmber Canada - subsidiary

BioAmber Inc. the parent company, BioAmber Sarnia and BioAmber
tdbowieknife tdbowieknife 4 minutos hace
Ok... It "trades" on two different markets, controlled by two different regulators, in two different Countries...

Wow....

Worried a bit??

..


.
TWOH
getmoreshares getmoreshares 5 minutos hace
COIN UP!!!!!!!!
CGAC
getmoreshares getmoreshares 5 minutos hace
i do not reveal my holding amounts-- will say-- did not sell a single share(all holdings) last year-- have been adding many positions all year. I do NOT FLIP- the TAX man gets enough.
HOMU
marcis marcis 6 minutos hace
OTCMARKETS will no longer require attorney letter for PINK current Status as of 01/31/25. Instead, a Management Certification will be required.
RDAR
MartinLutherKing MartinLutherKing 6 minutos hace
RNAZ microRNA technology was recognized with the 2024 Nobel Prize in Physiology and Medicine
TransCode is the only company with an ongoing US clinical trial targeting microRNA in cancer with 2.3Million market cap with 696K outstanding shares
RNAZ
Nerdy1 Nerdy1 7 minutos hace
💯 agree I believe that this will all be revealed and this will be one of the most interesting case studies in Business schools in the future. But in the moment we must fight. What is to stop the government from just taking them over again? What is to stop them from taking over other companie
FNMA
govprs govprs 7 minutos hace
I wasn't sure all of December but I feel more sure now.  Btw  I'm speculating we might see a series of PRs thru March.   So much in play now.  If I'm correct he will be chasing 😀
GDVM
MartinLutherKing MartinLutherKing 9 minutos hace
Is RNAZ An empty shell company
RNAZ
StayHumble StayHumble 9 minutos hace
💹💹 https://theqcup.com/patents $HCMC PATENT💹Intellectual Property Holdings, LLC, holds + markets $HCMC intellectual property assets. This subsidiary owns all patents, trademarks & other intellectual property of $HCMC & will be utilized to monetize its intellectual property
HCMC
SurgeGuy2.0 SurgeGuy2.0 9 minutos hace
Buying low to sell high again! SURG is a sure bargain!!!!!!
SURG
JERSEYHAWG JERSEYHAWG 9 minutos hace
Mellon. I will say this.
NOT DISRESPECTFULLY CONFUSED.

just confused. No more than that.

As I said. Your a good addition here. With good posts
LEHNQ
Shawonsarker84 Shawonsarker84 9 minutos hace
The #HMBL Brand is No Longer
Owned under $HMBL

@EuThiago_Moura
Time for $FinCapital's Ticker Change?

IMO Make that $37M (20 mag silicate + 17 holdco unit) in assets better known.

Will FinCapital be where YBYRA stores the other $1B of ferti
FINCAPITAL HMBL THEPAYGROU
236T568 236T568 10 minutos hace
What in the world is she doing to herself? 

Find some previous pictures and compare 

https://x.com/IAmSophiaNelson/status/1876120418500923470?s=19
ron_66271 ron_66271 11 minutos hace
JPM is Responsible for LEHMANS Bankruptcy.

JPM made a loan to Lehman’s of ~$17 Billion at the end of each day for Lehman’s to close their books “Mark to Market”.

On September 14th, JPM didn’t have the money to cover Lehman’s draw because JPM couldn’t cover their Derivat
JPM
JERSEYHAWG JERSEYHAWG 12 minutos hace
My reply. From the old guy.
I don't think it's a sophisticated e mail chain
It was just a email. Snd after I had n dug I hot who it was that sent it. A acquaintance friend that's just a barley no one like me.

And trust me. I don't follow you on any sites
Lol
LEHNQ
marcis marcis 12 minutos hace
Question
How much do you held
Or sell to take down the SP like other stocks
HOMU
Lime Time Lime Time 12 minutos hace
It's actually not listed at all. It trades on a market. And will resume soon once the halt is lifted
TWOH
StayHumble StayHumble 14 minutos hace
💹 7/7/23 $HCMC entered a 💹VapePatent LicensingAgreement 💹

Granting licensee a non-exclusive right & license to make|use|offer|sell, sell,& import licensed products in the USA. Licensee will pay based on net sales of all products @healthiercmc
https://dd7
HCMC
StayHumble StayHumble 16 minutos hace
💹wow 💹a $5M $HCMC💹💹BUYBACK💹 💹 💹

-A buyback of up to $5M of $HCMC common stock.

-A spinoff of certain HCMC assets into a new publicly traded company

-A stock dividend to $HCMC shareholders of the stoc
HCMC
CrossFireTrader CrossFireTrader 16 minutos hace
Well you may be right because that's his MO
GDVM
trader59 trader59 16 minutos hace
That isn't what it says, read for understanding. There were no agreements between the secured creditors and Visolis, the agreements were between the secured creditors dividing up the proceeds, first between BioAmber, Inc and BioAmber Sarnia, which then was divided between the creditors.
JERSEYHAWG JERSEYHAWG 16 minutos hace
Ok.

I am just lost on this.
No problem here.
LEHNQ
3331 3331 16 minutos hace
BIEL: HUGE HIT IN TAIWAN!
https://www.actipatchtw.com/general-1
Pickme2 Pickme2 16 minutos hace
More like 42,400,000 million total shares registering per the S-1 security exchange commission filing and  style="font-size: 1em"Add the existing ("ungagged unrestricted shares as the Cons call it" ) 2,901,188 million for a total of 45,301,188 million ungagged unrestricted shares registered once the
ATMH

Su Consulta Reciente

TG
0M4
Mersana Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados